UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Validation of the Dutch Version of the DN4 Diagnostic Questionnaire for Neuropathic Pain

Pain practice, 2013-06, Vol.13 (5), p.390-398

2013

Volltextzugriff (PDF)

Reduced Productivity after Sickness Absence Due to Musculoskeletal Disorders and Its Relation to Health Outcomes

Scandinavian Journal of Work, Environment ＆ Health, 2005-10, Vol.31 (5), p.367-374

2005

Volltextzugriff (PDF)

Antihypertensive Drugs: A Perspective on Pharmaceutical Price Erosion and Its Impact on Cost-Effectiveness

Value in health, 2012-03, Vol.15 (2), p.381-388

2012

Volltextzugriff (PDF)

Effectiveness of a back pain prevention program : A cluster randomized controlled trial in an occupational setting

Spine (Philadelphia, Pa. 1976), 2007-04, Vol.32 (7), p.711-719

2007

Volltextzugriff (PDF)

The Relationship between Productivity and Health-Related Quality of Life: An Empirical Exploration in Persons with Low Back Pain

Quality of life research, 2005-04, Vol.14 (3), p.805-813

2005

Volltextzugriff (PDF)

Human papillomavirus triage of women with persistent borderline or mildly dyskaryotic smears: Comparison of costs and side effects of three alternative strategies

International journal of cancer, 2007-10, Vol.121 (7), p.1529-1535

2007

Volltextzugriff (PDF)

Assessing the burden of injury in six European countries

Bulletin of the World Health Organization, 2007-01, Vol.85 (1), p.27-34

2007

Volltextzugriff (PDF)

Individual differences in the use of the response scale determine valuations of hypothetical health states: an empirical study

BMC health services research, 2007-04, Vol.7 (1), p.62-62, Article 62

2007

Volltextzugriff (PDF)

Measuring productivity changes in economic evaluation: Setting the research agenda

PharmacoEconomics, 2005, Vol.23 (1), p.47-54

2005

Volltextzugriff (PDF)

Cholesterol Level Goal Attainment with Statins: Clinical Management Guideline Recommendations versus Management in Actual Clinical Practice

Pharmacotherapy, 2012-07, Vol.32 (7), p.631-641

2012

Volltextzugriff (PDF)

Preferences of GPs and Patients for Preventive Osteoporosis Drug Treatment: A Discrete-Choice Experiment

PharmacoEconomics, 2009-01, Vol.27 (3), p.211-219

2009

Volltextzugriff (PDF)

Social Time Preferences for Health and Money Elicited with a Choice Experiment

Value in health, 2010-06, Vol.13 (4), p.368-374

2010

Volltextzugriff (PDF)

The relationship between productivity and health-related QOL : An exploration

PharmacoEconomics, 2005-01, Vol.23 (3), p.209-218

2005

Volltextzugriff (PDF)

Correcting for compensating mechanisms related to productivity costs in economic evaluations of health care programmes

Health economics, 2005-05, Vol.14 (5), p.435-443

2005

Volltextzugriff (PDF)

Determination of non-treatment with statins of high risk patients in the Netherlands

Current medical research and opinion, 2010-02, Vol.26 (2), p.271-278

2010

Volltextzugriff (PDF)

Guidelines for the Conduction of Follow-up Studies Measuring Injury-Related Disability

The Journal of trauma, injury, infection, and critical care, 2007-02, Vol.62 (2), p.534-550

2007

Volltextzugriff (PDF)

How adequate are emergency department home and leisure injury surveillance systems for cross-country comparisons in Europe?

International journal of injury control and safety promotion, 2010-03, Vol.17 (1), p.13-22

2010

Volltextzugriff (PDF)

Costs, Benefits and Effectiveness of Worksite Physical Activity Counseling from the Employer's Perspective

Scandinavian Journal of Work, Environment ＆ Health, 2004-02, Vol.30 (1), p.36-46

2004

Volltextzugriff (PDF)

Who contextualises clinical epidemiological evidence? A political analysis of the problem of evidence-based medicine in the layered Dutch healthcare system

Health policy (Amsterdam), 2021-01, Vol.125 (1), p.34-40

2021

Volltextzugriff (PDF)

Functional Outcome at 2.5, 5, 9, and 24 Months After Injury in the Netherlands

The Journal of trauma, injury, infection, and critical care, 2007-01, Vol.62 (1), p.133-141

2007

Volltextzugriff (PDF)

ECONOMIC IMPLICATIONS OF HEALTH INEQUALITIES IN THE EUROPEAN UNION

Journal of epidemiology and community health (1979), 2010-12, Vol.65 (5)

2010

Volltextzugriff (PDF)

Incidence and costs of injuries in The Netherlands

European journal of public health, 2006-06, Vol.16 (3), p.271-277

2006

Volltextzugriff (PDF)

Abstract P264: The Health and Economic Impact of Switching From Atorvastatin to Generic Simvastatin in the Netherlands

Circulation Cardiovascular quality and outcomes, 2011-11, Vol.4 (suppl_1)

2011

Volltextzugriff (PDF)

Abstract P100: The Cardiovascular Consequences of Switching From Atorvastatin to Generic Simvastatin in the Netherlands

Circulation Cardiovascular quality and outcomes, 2011-11, Vol.4 (suppl_1)

2011

Volltextzugriff (PDF)

Demographic and epidemiological determinants of healthcare costs in Netherlands: cost of illness study

BMJ, 1998-07, Vol.317 (7151), p.111-115

International edition, 1998

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(46)

Publikationsform

Artikel
(51)

Sprache

Englisch
(50)
Portugiesisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(33)
Life Sciences & Biomedicine
(33)
Science & Technology
(33)
Female
(25)
Male
(22)
Middle Aged
(22)
Adult
(20)
Biological And Medical Sciences
(17)
Medical Sciences
(17)
Aged
(15)
Netherlands
(15)
Health Care Sciences & Services
(11)
Public, Environmental & Occupational Health
(11)
Adolescent
(10)
Health Policy & Services
(10)
Social Sciences
(8)
Surveys And Questionnaires
(8)
Time Factors
(8)
Wounds And Injuries - Epidemiology
(8)
Business & Economics
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Validation of the Dutch Version of the DN4 Diagnostic Questionnaire for Neuropathic Pain

Reduced Productivity after Sickness Absence Due to Musculoskeletal Disorders and Its Relation to Health Outcomes

Antihypertensive Drugs: A Perspective on Pharmaceutical Price Erosion and Its Impact on Cost-Effectiveness

Effectiveness of a back pain prevention program : A cluster randomized controlled trial in an occupational setting

The Relationship between Productivity and Health-Related Quality of Life: An Empirical Exploration in Persons with Low Back Pain

Human papillomavirus triage of women with persistent borderline or mildly dyskaryotic smears: Comparison of costs and side effects of three alternative strategies

Assessing the burden of injury in six European countries

Individual differences in the use of the response scale determine valuations of hypothetical health states: an empirical study

Measuring productivity changes in economic evaluation: Setting the research agenda

Cholesterol Level Goal Attainment with Statins: Clinical Management Guideline Recommendations versus Management in Actual Clinical Practice

Preferences of GPs and Patients for Preventive Osteoporosis Drug Treatment: A Discrete-Choice Experiment

Social Time Preferences for Health and Money Elicited with a Choice Experiment

The relationship between productivity and health-related QOL : An exploration

Correcting for compensating mechanisms related to productivity costs in economic evaluations of health care programmes

Determination of non-treatment with statins of high risk patients in the Netherlands

Guidelines for the Conduction of Follow-up Studies Measuring Injury-Related Disability

How adequate are emergency department home and leisure injury surveillance systems for cross-country comparisons in Europe?

Costs, Benefits and Effectiveness of Worksite Physical Activity Counseling from the Employer's Perspective

Who contextualises clinical epidemiological evidence? A political analysis of the problem of evidence-based medicine in the layered Dutch healthcare system

Functional Outcome at 2.5, 5, 9, and 24 Months After Injury in the Netherlands

ECONOMIC IMPLICATIONS OF HEALTH INEQUALITIES IN THE EUROPEAN UNION

Incidence and costs of injuries in The Netherlands

Abstract P264: The Health and Economic Impact of Switching From Atorvastatin to Generic Simvastatin in the Netherlands

Abstract P100: The Cardiovascular Consequences of Switching From Atorvastatin to Generic Simvastatin in the Netherlands

Demographic and epidemiological determinants of healthcare costs in Netherlands: cost of illness study

Suchergebnisse filtern